Unilateral Deep Brain Stimulation of Globus Pallidus internus and Medial Intermediate Ventral Nuclei of the Optic Thalamus combined in a case of Dystonia Myoclonus with good evolution after 6 years of follow-up.
DOI:
https://doi.org/10.47924/neurotarget202113Keywords:
Myoclonic Deep Brain Stimulation, Dystonia, Intermediate Ventral Nucleus, internal globus pallidus, ThalamusAbstract
Introduction: Myoclonus dystonia syndrome (MDS) is an autosomal dominant or sporadic disorder characterized by slowly progressive myoclonic jerks and dystonia that sometimes becomes disabling. The objective of our work to demonstrate the possibility of good long-term functional results, and to analyze the respective literature on the state of the art on the subject.
Materials and methods: We present a clinical case of a 61-year-old patient with advanced and refractory symptoms, operated on in July 2014 with good evolution, according to the Burn-Fahn- Madsen and QoL scales. The examination of the bibliography was carried out through Pubmed, Latindex, Scielo and Medline, examining more than two thousand works published in four languages (English, French, Portuguese and Spanish). Results: We present a 61-year-old patient, who to date presents sustained improvement more than 6 years after his surgical intervention. Findings in the literature point to the possibility of obtaining occasional prolonged improvements, but we obtained little information on the use and results of the combined method. Conclusions: MDS has occasionally been successfully treated with combined stimulation on occasion, but over the past 10 years its use appears to have been reduced or abandoned. The publication of this case with prolonged improvement aims to relaunch the combined method as a treatment.
Metrics
References
Kinugawa K, Vidailhet M, Clot F, Apartis E, Grabli D, Roze E. Myoclonus-Dystonia: An Update. Movement Disorders. 2009; 24(4): 479–489.
Rocha H, Linhares P, Chamadoira C, Rosas MJ, Vaz R. Early deep brain stimulation in patients with myoclonus-dystonia syndrome. J Clin Neurosci. 2016. DOI 10.1016/j.jocn.2015.08.034.
Rachad L, El Kadmiri N, Slassi I, El Otmani H, Nadifi S. Genetic Aspects of Myoclonus–Dystonia Syndrome (MDS). Mol Neurobiol. DOI 10.1007/s12035-016-9712-x.
Luciano A, Jinnah H, Pfeiffer R, Truong D, Nance M, LeDoux M. Treatment of Myoclonus-Dystonia Syndrome with Tetrabenazine. Parkinsonism Relat Disord. 2014; 20(12): 1423–1426.
Nardocci N. Myoclonus-Dystonia Syndrome. Handbook of Clinical Neurology. 2011; 100
Rughani AI, Lozano AM, Surgical Treatment of Myoclonus Dystonia Syndrome. Movement Disorders. 2013; 28(3).
Gruber D et al. Pallidal and Thalamic Deep Brain Stimulation in Myoclonus-Dystonia. Movement Disorders. 2010; 25(11).
Oropilla JQL. Both thalamic and pallidal deep brain stimulation for myoclonic dystonia. J Neurosurg. 2010; 112:1267–1270.
Wang JW, Li JP, Wang JP, et al. Deep brain stimulation for myoclonus-dystonia syndrome with double mutations in DYT1 and DYT11. Sci Rep. 2017; 19(7):41-42.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Dr. Fabián Piedimonte, Dra. Verónica Montilla, Dra. Laura Contartese, Dr. Juan Carlos Andreani

This work is licensed under a Creative Commons Attribution 4.0 International License.
The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.